An index with improved diagnostic accuracy for the diagnosis of Crohn's disease derived from the Lennard-Jones criteria

Alimentary Pharmacology and Therapeutics

Volumn 44, Issue 6, 2016, Pages 601-611

  Reinisch, S ^a   Schweiger, K ^b   Pablik, E ^a   Collet Fenetrier, B ^c   Peyrin Biroulet, L ^c   Alfaro, I ^d   Panes J ^d   Moayyedi, P ^e   Reinisch, W ^a,e  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; FIBROSIS; GRANULOMA; HUMAN; LENNARD JONES CRITERIA; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS; VALIDITY;

EID: 84981186412     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13727     Document Type: Article

References (26)

1. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006; 12(Suppl. 1): 3–9.
2. Prinz G, Novacek G, Vogelsang H, et al. Time to diagnosis in IBD patients belonging to a self-help group. J Crohns Colitis 2007; 1(Suppl): 26, P090 (abstract).
3. Pimentel M, Chang M, Chow WJ, et al. Identification of prodromal period in Crohn's disease but not in ulcerative colitis. Am J Gastroenterol 2000; 95: 3458–62.
4. Peminow G, Brackmann S, Lyckander LG, et al. A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn's disease. Scand J Gasteroenterol 2009; 44: 446–56.
5. Romberg-Camps MJ, Hesselink-van de Kruijs MA, Schouten LJ, et al. Inflammatory bowel disease in South Limburg (the Netherlands) 1991-2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms. J Crohns Colitis 2009; 3: 115–24.
6. Angelberger S, Vogelsang H, Novacek G, et al. Public awareness of Crohn's disease and ulcerative colitis: a national survey. J Crohns Colitis 2009; 3: 157–61.
7. Vavricka SR, Spgaglia SM, Rogler G, et a. Systemic evaluation of the risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 496–505.
8. Baert F, Moortgat L, Van Assche G, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010; 138: 463–8.
9. D'Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 2008; 371: 660–7.
10. Schreiber S, Reinisch W, Colombel JF, et al. Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease. J Crohns Colitis 2013; 7: 213–21.
11. Solberg IC, Vatn MH, Høie O, et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007; 5: 1430–8.
12. Van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010; 4: 7–27.
13. Lennard-Jones JE, Shivananda S; the EC-IBD study group. Clinical uniformity of inflammatory bowel disease at the presentation and during the first year of disease in the north and south of Europe. Eur J Gastroenterol Hepatol 1997; 9: 353–9.
14. Peyrin-Biroulet L, Billioud V, D'Haens G, et al. Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process. Am J Gastroenterol 2012; 107: 1770–6.
15. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19(Suppl. A): 5–36.
16. Heinze G, Ploner M, Dunkler D, Southworth H. logistf: Firth's bias reduced logistic regression, 2013. R package version 1.21. http://CRAN.R-project.org/package=logistf
17. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2014. Available at: http://www.R-project.org/
18. Sjöberg D, Holmström T, Larsson M, et al. Incidence and clinical course of Crohn's disease during the first year -results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009. J Crohns Colitis 2014; 8: 215–22.
19. Ramadas AV, Gunesh S, Thomas GA, et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010; 59: 1200–6.
20. Feakins RM. Ulcerative colitis or Crohn's disease? Pitfalls and problems Histopathology 2014; 64: 317–35.
21. Rubio CA, Orrego A, Nesi G, et al. Frequency of epithelioid granulomas in colonoscopic biopsy specimens from paediatric and adult patients with Crohn's colitis. J Clin Pathol 2007; 60: 1268–72.
22. De Matos V, Russo PA, Cohen AB, et al. Frequency and clinical correlations of granulomas in children with Crohn disease. J Pediatr Gastroenterol Nutr 2008; 46: 392–8.
23. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569–81.
24. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010; 69: 1580–8.
25. Biliavska I, Stamm TA, Martinez-Avila J, et al. Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort. Ann Rheum Dis 2013; 72: 1335–41.
26. Bossuyt X. Serologic markers in inflammatory bowel disease. Clin Chem 2006; 52: 171–81.